The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): A prospective cohort study of childhood nephrotic syndrome

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Hussain, Neesha ^b   Zello, J Anastasia ^e   Vasilevska Ristovska, Jovanka ^b   Banh, Tonny M ^d   Patel, Viral P ^d   Patel, Pranali ^b   Battiston, Christopher D ^b   Hebert, Diane ^a,d   Licht, Christoph P B ^a,d   Piscione, Tino D ^a,d   Parekh, Rulan S ^a,b,c,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Children; Chronic kidney disease; Cohort; FSGS; Minimal change disease; Nephrotic syndrome; Study protocol

Indexed keywords

PREDNISONE;

ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; HEREDITY; HUMAN; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NAIL; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; STEROID THERAPY; TREATMENT RESPONSE; URINALYSIS;

CAUSALITY; CHILD; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; NEPHROTIC SYNDROME; ONTARIO; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS;

EID: 84872771607     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-25     Document Type: Article

References (63)

1. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. ISKDC, Kidney Int 1981 20 6 765 771 7334749
2. Nephrotic syndrome in childhood. Eddy AA, Symons JM, Lancet 2003 362 9384 629 639 10.1016/S0140-6736(03)14184-0 12944064 (Pubitemid 37013306)
3. Steroid-resistant nephrotic syndrome: the influence of race on cyclophosphamide sensitivity. Bhimma R, Adhikari M, Asharam K, Pediatr Nephrol 2006 21 12 1847 1853 10.1007/s00467-006-0276-2 16967286 (Pubitemid 44741162)
4. Childhood nephrotic syndrome in Cambodia: an association with gastrointestinal parasites. Copelovitch L, Sam Ol O, Taraquinio S, Chanpheaktra N, J Pediatr 2010 156 1 76 81 10.1016/j.jpeds.2009.06.049 19683254
5. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Ingulli E, Tejani A, Pediatr Nephrol 1991 5 4 393 397 10.1007/BF01453661 1911111
6. Histopathological spectrum of childhood nephrotic syndrome in Pakistan. Mubarak M, Lanewala A, Kazi JI, Akhter F, Sher A, Fayyaz A, Bhatti S, Clin Exp Nephrol 2009 13 6 589 593 10.1007/s10157-009-0216-0 19636666
7. Treatment of the nephrotic syndrome in childhood: Use of an alternate-day prednisone regimen. Soyka LF, Arch Pediatr Adolesc Med 1967 113 6 693 701 10.1001/archpedi.1967.02090210107011
8. Childhood idiopathic nephrotic syndrome in Turkey. Bircan Z, Yavuz Yilmaz A, Katar S, Vitrinel A, Yildirim M, Pediatr Int 2002 44 6 608 611 12421256 (Pubitemid 35357025)
9. Primary nephrotic syndrome during childhood in Turkey. Ozkaya N, Cakar N, Ekim M, Kara N, Akkok N, Yalcinkaya F, Pediatr Int 2004 46 4 436 438 10.1111/j.1442-200x.2004.01920.x 15310309 (Pubitemid 39119157)
10. High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kim JS, Bellew CA, Silverstein DM, Aviles DH, Boineau FG, Vehaskari VM, Kidney Int 2005 68 3 1275 1281 10.1111/j.1523-1755.2005.00524.x 16105061 (Pubitemid 43246447)
11. Clinicopathological features and prognosis of Chinese children with idiopathic nephrotic syndrome between different age groups. Chang JW, Tsai HL, Wang HH, Yang LY, Eur J Pediatr 2009 168 10 1189 1194 10.1007/s00431-008-0902-z 19101727
12. Management and outcome of steroid-resistant nephrotic syndrome in children. Otukesh H, Otukesh S, Mojtahedzadeh M, Hoseini R, Fereshtehnejad SM, Riahi Fard A, Sadigh N, Heshmatzade Behzadi A, Javadi R, Hooman N, Iran J Kidney Dis 2009 3 4 210 217 19841524
13. The increasing incidence of initial steroid resistance in childhood nephrotic syndrome. Banaszak B, Banaszak P, Pediatr Nephrol 2012 27 6 927 932 10.1007/s00467-011-2083-7 22231438
14. Histopathological spectrum of childhood nephrotic syndrome in Indian children. Kumar J, Gulati S, Sharma AP, Sharma RK, Gupta RK, Pediatr Nephrol 2003 18 7 657 660 12743793 (Pubitemid 36826849)
15. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. Wong W, J Paediatr Child Health 2007 43 5 337 341 10.1111/j.1440-1754.2007.01077.x 17489822 (Pubitemid 46698298)
16. Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature. El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, Van Wijk JA, Pediatr Nephrol 2011 26 8 1241 1246 10.1007/s00467-011-1851-8 21533870
17. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. ISKDC, J Pediatr 1981 98 4 561 564 7205481
18. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 1978 13 2 159 165 713276
19. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Nat Genet 2008 40 10 1185 1192 10.1038/ng.232 18794854
20. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Nat Genet 2008 40 10 1175 1184 10.1038/ng.226 18794856
21. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Science 2010 329 5993 841 845 10.1126/science.1193032 20647424
22. APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, J Am Soc Nephrol 2011 22 11 2129 2137 10.1681/ASN.2011040388 21997394
23. The MYH9/APOL1 region and chronic kidney disease in European-Americans. O'Seaghdha CM, Parekh RS, Hwang S-J, Li M, Köttgen A, Coresh J, Yang Q, Fox CS, Kao WHL, Hum Mol Genet 2011 20 12 2450 2456 10.1093/hmg/ddr118 21429915
24. Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA, PLoS One 2010 5 7 11474 10.1371/journal.pone. 0011474 20634883
25. Mercury and the kidney. George CR, J Nephrol 2011 24 Suppl 17 126 S132 21614794
26. Steroid-responsive and nephrotic syndrome and allergy: clinical studies. Meadow SR, Sarsfield JK, Arch Dis Child 1981 56 7 509 516 10.1136/adc.56.7.509 6791592 (Pubitemid 11053059)
27. Relationship between serum IgE and frequent relapse idiopathic nephrotic syndrome. Jahan I, Hanif M, Ali MA, Waliullah SM, Mia AH, Mymensingh medical journal: MMJ 2011 20 3 484 489 21804516
28. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Cheung W, Wei CL, Seah CC, Jordan SC, Yap HK, Pediatr Nephrol 2004 19 6 627 632 10.1007/s00467-004-1438-8 15064938 (Pubitemid 38771733)
29. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: Evidence of early effects and multiple interactions at environmental exposure levels. de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A, Smerhovsky Z, Cikrt M, Trzcinka-Ochocka M, Razniewska G, Environ Health Perspect 2006 114 4 584 590 16581550
30. Effects of nephrotic syndrome on the family: A controlled study. Vance JC, Fazan LE, Satterwhite B, Pless IB, Pediatrics 1980 65 5 948 955 7367140 (Pubitemid 10068350)
31. The effect of chronic nephrotic syndrome on the affected child. Vance JC, Pless IB, J Dev Behav Pediatr 1983 4 3 159 162 10.1097/00004703-198309000-00003 6630530 (Pubitemid 14226691)
32. Neural deficits, intelligence, maladjustment and family response in children with the nephrotic syndrome. Naidoo LR, Moodley TY, Coovadia HM, Adhikari M, Samj S Afr Med J 1987 71 1 9 10 (Pubitemid 17008788)
33. Behavior problems in nephrotic syndrome. Mehta M, Bagga A, Pande P, Bajaj G, Srivastava RN, Indian Pediatr 1995 32 12 1281 1286 8772885
34. Family structure and the course of steroid-sensitive nephrotic syndrome. Soliday E, Lande MB, Pediatr Nephrol 2002 17 1 41 44 10.1007/s004670200007 11793133 (Pubitemid 41490203)
35. Daily reports and pooled time series analysis: Pediatric psychology applications. Soliday E, Moore KJ, Lande MB, J Pediatr Psychol 2002 27 1 67 76 10.1093/jpepsy/27.1.67 11726681 (Pubitemid 34019649)
36. The effects of corticosteroids on behavior in children with nephrotic syndrome. Hall AS, Thorley G, Houtman PN, Pediatr Nephrol 2003 18 12 1220 1223 10.1007/s00467-003-1295-x 14577022 (Pubitemid 37527094)
37. Health-related quality of life and psychosocial adjustment in steroid-sensitive nephrotic syndrome. Ruth EM, Landolt MA, Neuhaus TJ, Kemper MJ, J Pediatr 2004 145 6 778 783 10.1016/j.jpeds.2004.08.022 15580200 (Pubitemid 39586616)
38. Behavior profile of children with nephrotic syndrome. Guha P, De A, Ghosal M, Indian Journal of Psychiatry 2009 51 2 122 126 10.4103/0019-5545.49452 19823631
39. The impact of pediatric nephrotic syndrome on families. Mitra S, Banerjee S, Pediatr Nephrol 2011 26 8 1235 1240 10.1007/s00467-011-1841-x 21626223
40. Gene-environment interaction and children's health and development. Wright RO, Christiani D, Curr Opin Pediatr 2010 22 2 197 201 10.1097/MOP.0b013e328336ebf9 20090521
41. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WHL, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Kidney Int 2013 83 1 114 120 10.1038/ki.2012.263 22832513
42. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Varni JW, Seid M, Kurtin PS, Med Care 2001 39 8 800 812 10.1097/00005650- 200108000-00006 11468499 (Pubitemid 33686263)
43. Ontario Child Health Study: reliability and validity of the general functioning subscale of the McMaster Family Assessment Device. Byles J, Byrne C, Boyle MH, Offord DR, Fam Process 1988 27 1 97 104 10.1111/j.1545-5300.1988. 00097.x 3360100
44. An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4. Kroenke K, Spitzer RL, Williams JBW, Lowe B, Psychosomatics 2009 50 6 613 621 19996233
45. A 4-item measure of depression and anxiety: Validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E, J Affect Disord 2010 122 1-2 86 95 19616305
46. Development of a brief test to measure functional health literacy. Baker DW, Williams MV, Parker RM, Gazmararian JA, Nurss J, Patient Educ Couns 1999 38 1 33 42 10.1016/S0738-3991(98)00116-5 14528569 (Pubitemid 29413035)
47. Management of childhood onset nephrotic syndrome. Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Pediatrics 2009 124 2 747 757 10.1542/peds.2008-1559 19651590
48. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J, Pediatrics 2000 105 6 1242 1249 10.1542/peds.105.6.1242 10835064 (Pubitemid 30346893)
49. Monitoring of cadmium, copper, lead and zinc status in young children using toenails: comparison with scalp hair. Wilhelm M, Hafner D, Lombeck I, Ohnosorge FK, Sci Total Environ 1991 103 2-3 199 207 1882232
50. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, Mahoney L, McCrindle B, Mietus-Snyder M, Steinberger J, Hypertension 2008 52 3 433 451 10.1161/HYPERTENSIONAHA.108.190329 18678786
51. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, J Biomedical Informatics 2009 42 2 377 381 10.1016/j.jbi.2008.08.010
52. 2008 Best Practices for Respositories: collection, storage, retrieval and distribution of biological materials for research: International Society for Biological and Environmental Repositories (ISBER). Cell Preserv Technol 2008 6 1 5+
53. Canada S, Low Income Lines, 2010 to 2011 Ottawa: Authority of the Minister Responsible for Statistics Canada, Industry, 2012 28 30 Volume 75F0002M
54. NPHS2 mutations in children with steroid-resistant nephrotic syndrome. Otukesh H, Ghazanfari B, Fereshtehnejad SM, Bakhshayesh M, Hashemi M, Hoseini R, Chalian M, Salami A, Mehdipor L, Rahiminia A, Iran J Kidney Dis 2009 3 2 99 102 19395786
55. Nephrotic Syndrome in the First Year of life: Two Thirds of Cases are Caused by Mutations in 4 Genes (NPHS1, NPHS2, WT1 and LAMB2). Hinkes BGMB, Vlangos CN, Gbadegsin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt and members of the Arbeitsgemeinschaft fur Paediatrische Nephologie Study Group, Paediatrics Int 2007 119 4 907 919 10.1542/peds.2006-2164 (Pubitemid 46556655)
56. Legacy Effects from DCCT and UKPDS: What They Mean and Implications for Future Diabetes Trials. Murray P, Chune G, Raghavan V, Curr Atheroscler Rep 2010 12 6 432 439 10.1007/s11883-010-0128-1 20652839
57. Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Genuth S, Nathan D, Shamoon H, Duffy H, Dahms B, Mayer L, Brillion D, Lackaye M, Whitehouse F, Kruger D, Diabetes Care 1999 22 1 99 111 10333910 (Pubitemid 29028305)
58. Insights from the Chronic Kidney Disease in Children (CKiD) Study. Copelovitch L, Warady BA, Furth SL, Clin J Am Soc Nephrol 2011 6 8 2047 2053 10.2215/CJN.10751210 21784815
59. Clinical Registry of SRNS Patients: http://www.podonet.org/opencms/ opencms/podonet/podonet-en/PodoNet-Projects/Clinical-Registry-Of-SRNS-Patients. html
60. RaDaR,: www.renalradar.org
61. Nephrotic Syndrome Study Network: https://rarediseasesnetwork.epi.usf. edu/NEPTUNE/index.htm
62. Psychosocial Aspects of Chronic Disease: ESRD as a Paradigmatic Illness. Cukor D, Cohen SD, Peterson RA, Kimmel PL, J Am Soc Nephrol 2007 18 12 3042 3055 10.1681/ASN.2007030345 18003775 (Pubitemid 350223964)
63. The psychosocial well-being of children with chronic disease, their parents and siblings: an overview of the research evidence base. Barlow JH, Ellard DR, Child Care Health Dev 2006 32 1 19 31 10.1111/j.1365-2214.2006.00591. x 16398788 (Pubitemid 43372440)